A Novel Approach: Brazil-US Partnerships in Health Science and Human Medicine — was the topic of the webinar held last Friday, October 27, by the Brazil-US Chamber of Commerce presenting the MBI experience! We thank BACC for the opportunity to showcase our work with the presence of our valuable partners — businessman William Ling, MBI donor, Ambassador Otávio Brandelli, and Dr. Roger Packer, leader of the Cure Group 4 Consortium.
“In Brazil, there are no incentives for such initiatives at all… the MBI is a rare case of cross border cooperation led by a brazilian citizen to find a solution that will impact the lives of uncountable children and families, and we are proud to be part of it.”
– William Ling
“It’s unprecedented for me in my life in all the 30 years of my career as a diplomat, I never had the opportunity to participate in something that is going to change humanity in the short term.”
– Ambassador Otávio Brandelli
“We knew we were getting a group of people who could work together, who would focus on the problem and would use the best science to give us our best option […] the best option in two years to try to save more children. I’ve been doing this for 40 years, taking care of children with brain tumors. This is an unparalleled opportunity. I wanna take it.”
– Dr. Roger J. Packer
“We want to save thousands of lives and find better treatment for children who are subjected to radiotherapy and chemotherapy with many side effects. We want to raise awareness about the lack of research and perhaps help other diseases that, like medulloblastoma, lack funding. And we want to be a reference for other families who can follow our example and perhaps make a difference.”
– Fernando Goldsztein
